The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children
- PMID: 22981874
- DOI: 10.1016/j.jocn.2012.04.009
The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children
Abstract
Medulloblastomas (MB) and primitive neurectodermal tumours (PNET) are known to affect children more than adults. To estimate the magnitude of the differences between the incidence of adults and children, the incidence rates, ratios and time trends of MB and PNET in children and adults are measured using data from the Surveillance, Epidemiology and End-Results (SEER) database. Between 1973 and 2007 in the SEER 9 registries, 1372 people were diagnosed with a MB and 530 with a PNET. The overall incidence rate of MB and PNET is approximately 1.5 and 0.62 per million population in the USA. Children (1-9 years of age) with MB had an incidence rate of 6.0, compared to 0.6 in adults, and therefore children are 10 times more likely to be affected by an MB than adults. Children are 4.6 times as likely to be afflicted by a PNET than adults. The difference in incidence rates based on sex existed only in children. Our study confirmed that the incidence rates of MB has not changed over time.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs).Cancer. 2012 Mar 1;118(5):1313-22. doi: 10.1002/cncr.26387. Epub 2011 Aug 11. Cancer. 2012. PMID: 21837678
-
Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results.Med Pediatr Oncol. 2002 Sep;39(3):190-4. doi: 10.1002/mpo.10121. Med Pediatr Oncol. 2002. PMID: 12210449
-
Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.Acad Radiol. 2012 Jan;19(1):35-9. doi: 10.1016/j.acra.2011.08.018. Epub 2011 Nov 3. Acad Radiol. 2012. PMID: 22054800
-
Medulloblastomas-primitive neuroectodermal tumours in the adult population.J Med Imaging Radiat Oncol. 2008 Feb;52(1):72-6. doi: 10.1111/j.1440-1673.2007.01915.x. J Med Imaging Radiat Oncol. 2008. PMID: 18373831 Review.
-
Primary intracranial neoplasms of infancy and early childhood.Childs Nerv Syst. 1997 Oct;13(10):507-13. doi: 10.1007/s003810050127. Childs Nerv Syst. 1997. PMID: 9403197 Review.
Cited by
-
Adjuvant chemotherapy and overall survival in adult medulloblastoma.Neuro Oncol. 2017 Feb 1;19(2):259-269. doi: 10.1093/neuonc/now150. Neuro Oncol. 2017. PMID: 27540083 Free PMC article.
-
Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.Diagnostics (Basel). 2021 Dec 28;12(1):61. doi: 10.3390/diagnostics12010061. Diagnostics (Basel). 2021. PMID: 35054230 Free PMC article. Review.
-
Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives.Cancers (Basel). 2021 Nov 26;13(23):5945. doi: 10.3390/cancers13235945. Cancers (Basel). 2021. PMID: 34885055 Free PMC article. Review.
-
Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy.Curr Treat Options Oncol. 2021 Jul 30;22(9):83. doi: 10.1007/s11864-021-00874-9. Curr Treat Options Oncol. 2021. PMID: 34328587 Review.
-
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23.Cancers (Basel). 2021 Jul 9;13(14):3451. doi: 10.3390/cancers13143451. Cancers (Basel). 2021. PMID: 34298664 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous